Syncom Formulations (India) Limited

NSEI:SYNCOMF Stock Report

Market Cap: ₹13.8b

Syncom Formulations (India) Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Syncom Formulations (India).

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth16.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article May 26

Here's Why Syncom Formulations (India) (NSE:SYNCOMF) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysis Article Feb 02

Here's Why We Think Syncom Formulations (India) (NSE:SYNCOMF) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article May 19

Syncom Formulations (India) Limited's (NSE:SYNCOMF) Business Is Trailing The Market But Its Shares Aren't

When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 27x, you may consider Syncom...
Analysis Article Mar 08

Should You Be Adding Syncom Formulations (India) (NSE:SYNCOMF) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article Jan 11

Does Syncom Formulations (India) (NSE:SYNCOMF) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Dec 10

Getting In Cheap On Syncom Formulations (India) Limited (NSE:SYNCOMF) Is Unlikely

With a price-to-earnings (or "P/E") ratio of 67x Syncom Formulations (India) Limited ( NSE:SYNCOMF ) may be sending...
Analysis Article Aug 30

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have continued their recent momentum with a 27% gain in the...
Analysis Article Jul 16

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shareholders have had their patience rewarded with a 27% share...
Analysis Article Mar 21

Some Syncom Formulations (India) Limited (NSE:SYNCOMF) Shareholders Look For Exit As Shares Take 28% Pounding

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have had a horrible month, losing 28% after a relatively...
Analysis Article Dec 29

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Despite an already strong run, Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shares have been powering on, with a...
Analysis Article Dec 27

Syncom Formulations (India) Limited's (NSE:SYNCOMF) Shares Climb 26% But Its Business Is Yet to Catch Up

Syncom Formulations (India) Limited ( NSE:SYNCOMF ) shareholders would be excited to see that the share price has had a...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Syncom Formulations (India) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:SYNCOMF - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20264,892764464581N/A
12/31/20255,026690N/AN/AN/A
9/30/20255,150631555736N/A
6/30/20254,947576N/AN/AN/A
3/31/20254,650494135234N/A
12/31/20243,907391N/AN/AN/A
9/30/20243,283331-90-51N/A
6/30/20242,908286N/AN/AN/A
3/31/20242,634253-141-60N/A
12/31/20232,498264N/AN/AN/A
9/30/20232,42023535170N/A
6/30/20232,327206N/AN/AN/A
3/31/20232,243201-101105N/A
12/31/20222,215164N/AN/AN/A
9/30/20222,213162-17650N/A
6/30/20222,198183N/AN/AN/A
3/31/20222,19719850163N/A
12/31/20212,270220N/AN/AN/A
9/30/20212,539280-83-70N/A
6/30/20212,668316N/AN/AN/A
3/31/20212,448292-47-21N/A
12/31/20202,223257N/AN/AN/A
9/30/20201,90519294113N/A
6/30/20201,809143N/AN/AN/A
3/31/20202,0551434159N/A
12/31/20192,237130N/AN/AN/A
9/30/20192,191133N/A87N/A
6/30/20192,077120N/AN/AN/A
3/31/20191,868111N/A43N/A
12/31/20181,648106N/AN/AN/A
9/30/20181,56697N/AN/AN/A
6/30/20181,50587N/AN/AN/A
3/31/20181,58686N/A-16N/A
3/31/20171,848105N/A138N/A
3/31/20161,839104N/A241N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SYNCOMF's forecast earnings growth is above the savings rate (6.9%).

Earnings vs Market: Insufficient data to determine if SYNCOMF's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if SYNCOMF's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SYNCOMF's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if SYNCOMF's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SYNCOMF's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/04 16:34
End of Day Share Price 2026/06/04 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Syncom Formulations (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.